pMN Clinical Trials

7 recruitingLast updated: May 21, 2026

There are 7 actively recruiting pmn clinical trials across 5 countries. Studies span Phase 2, Phase 4. Top locations include Amsterdam, Netherlands, Brisbane, California, United States, Fitzroy, Victoria, Australia. Updated daily from ClinicalTrials.gov.


pMN Trials at a Glance

7 actively recruiting trials for pmn are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 1 trial, with the heaviest enrollment activity in Amsterdam, Brisbane, and Fitzroy. Lead sponsors running pmn studies include IRCCS San Raffaele, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), and Changhai Hospital.

Browse pmn trials by phase

About pMN Clinical Trials

Looking for clinical trials for pMN? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new pMN trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about pMN clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Advanced Therapies for Liver Metastases

Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Liver Metastasis+1 more
IRCCS San Raffaele625 enrolled1 locationNCT04622423
Recruiting

AI-Powered Precision Decision-Making for Pancreatic Diseases

Pancreatic CancerPancreatic Neuroendocrine TumorChronic Pancreatitis+4 more
Changhai Hospital2,000 enrolled1 locationNCT07439757
Recruiting
Phase 2

Atacicept in Multiple Glomerular Diseases

IgANNephrotic SyndromeFSGS+2 more
Vera Therapeutics, Inc.200 enrolled1 locationNCT06983028
Recruiting
Phase 4

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Neuro Endocrine TumoursPDAC - Pancreatic Ductal AdenocarcinomaPancreas Adenocarcinoma+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)400 enrolled1 locationNCT07262957
Recruiting

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

IPMN, Pancreatic
IRCCS San Raffaele800 enrolled1 locationNCT06694792
Recruiting

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

IPMN, Pancreatic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3,600 enrolled2 locationsNCT06574373
Recruiting

Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer

IPMN, PancreaticIPMN
St Vincent's Hospital Melbourne1,000 enrolled1 locationNCT05117723